Akeso Highlights Collaboration Between Its Partner Summit Therapeutics and Pfizer to Explore Ivonescimab in Combination with Pfizer's ADCs
Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that its partner on ivonescimab, Summit Therapeutics Inc. (NASDAQ: SMMT) has entered into a clinical trial collaboration with Pfizer ...
Santa Rosa Press Democrat50m
Conductor Michael Tilson Thomas says brain tumor has returned
Michael Tilson Thomas’ brain tumor has returned, and the 80-year-old conductor intends to lead his final performance in April ...